Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here

Today's Daily Dose brings you news about Altimmune's AdCOVID vaccine, the growing list of approved indications for AbbVie's Botox, an update on Aldeyra's Dry Eye disease drug candidate Reproxalap and FDA approval of Merck's Keytruda for yet another indication.

from RTT - Biotech https://ift.tt/2ZcVQe3
via IFTTT